These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14769576)

  • 1. Interpectoral nodes as the initial site of recurrence in breast cancer.
    Komenaka IK; Bauer VP; Schnabel FR; Joseph KA; Horowitz E; Ditkoff BA; El-Tamer MB
    Arch Surg; 2004 Feb; 139(2):175-8. PubMed ID: 14769576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of abnormal Rotter's lymph nodes identified on preoperative breast magnetic resonance imaging.
    Kiluk JV; Khakpour N; Lee MC; Lowe J; Harris E; Szabunio M; Laronga C
    Am Surg; 2011 Jan; 77(1):E10-2. PubMed ID: 21396292
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].
    Ouyang T; Li JF; Wang TF; Lin BY
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer.
    Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W
    J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 7. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
    Davit FE; Gatmaitan P; Garguilo G
    Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node?
    Guth AA; Mercado C; Roses DF; Hiotis K; Skinner K; Diflo T; Cangiarella J
    Am J Surg; 2006 Oct; 192(4):502-5. PubMed ID: 16978960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
    Fan YG; Tan YY; Wu CT; Treseler P; Lu Y; Chan CW; Hwang S; Ewing C; Esserman L; Morita E; Leong SP
    Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
    Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
    Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-year follow-up after sentinel node mapping for breast cancer demonstrates better than expected treatment outcomes.
    Fuhrman GM; Gambino J; Bolton JS; Farr G; Jiang X
    Am Surg; 2005 Jul; 71(7):564-9; discussion 569-70. PubMed ID: 16089119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
    Newman EA; Cimmino VM; Sabel MS; Diehl KM; Frey KA; Chang AE; Newman LA
    Ann Surg Oncol; 2006 Jan; 13(1):52-7. PubMed ID: 16372155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
    Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.